『Picking Battles in the $5 Trillion Healthcare Market』のカバーアート

Picking Battles in the $5 Trillion Healthcare Market

Picking Battles in the $5 Trillion Healthcare Market

無料で聴く

ポッドキャストの詳細を見る

概要

 In this episode of Billion Dollar Moves, I sit down with David Berry, Co-Founder and Managing Partner of Averin Capital, for a conversation about building billion-dollar breakthroughs in healthcare. David has founded more than 30 companies, including seven valued over $1B, and has helped shape companies across biotech, AI drug discovery, microbiome therapeutics, agriculture, and health infrastructure. From losing a childhood friend to brain cancer, to asking why the hardest problems are worth pursuing, David shares how mission, science, and capital come together to create venture-scale healthcare companies. For founders, funders, and family offices investing in the future of health, this is a conversation about conviction, ethics, and building for impact at scale. Watch the full conversation and subscribe for more discussions at the intersection of capital, governance, and long-term wealth. 00:00 - Intro: Why go after the biggest problems? 01:12 - Truth vs. belief in science 03:00 - The myth that humans only use 10% of their brains 04:28 - Rethinking cancer and inherited assumptions 05:38 - How big ideas emerge from questioning “truth” 06:30 - Entrepreneur vs. investor: The N of one 08:10 - Building Seres Therapeutics and the microbiome frontier 11:00 - Turning strange science into a venture-scale company 12:20 - Why drug development does not always have to take 10–15 years 14:10 - Valo Health and AI-powered drug discovery 17:15 - Product-investor fit in biotech 20:30 - Why companies fail: Teams, resilience, and near-death moments 22:15 - Averin Capital and the transformation of health through technology 23:20 - BioLink and the future of continuous health monitoring 26:00 - Ozempic, access, and ethics in healthcare 31:10 - Women’s health, clinical trials, and bias in medical data 35:00 - David’s vision for Averin Capital 39:00 - How family offices should think about investing in health 40:00 - The next billion-dollar moves in healthcare 40:35 - Rapid fire About David Berry David is Co-Founder and Managing Partner at Averin. As an innovator and a company builder, he has been driven by the power of technology to transform industries. David has been a founder of over 30 companies, including 7 that have been valued at over $1B. David was previously a General Partner at Flagship Pioneering. He was also founder and CEO of Valo Health, where he raised over $500M and executed a transformative partnership with Novo Nordisk. David received his M.D. from Harvard Medical School and his Ph.D. from MIT through the biological engineering division, where he worked with Professors Robert Langer and Ram Sasisekharan. David works closely with Biolinq amongst other Averin companies. --- Billion Dollar Moves Podcast | The Top Global Venture & Business Podcast for Founders & Funders | Backed by HubSpot Podcast Network Conversations with billionaires, unicorn founders, and the world’s leading funders. Hosted by Sarah Chen-Spellings, Billion Dollar Moves examines how enduring companies — and the capital behind them — are built. Through long-form conversations, the show explores decision-making under uncertainty, capital allocation, and the inflection points that shape category-defining businesses. From early platform backstories to allocator frameworks used across private markets, the focus is on judgment, incentives, and long-term value creation — beyond headlines and hype. New episodes weekly. Built for those who take the long view. PODCAST INFO: Podcast website: https://billiondollarmoves.com Watch on Youtube: https://tinyurl.com/sarahchenglobal Join the community: https://sarah-chen.ck.page/billiondollarmoves FOLLOW SARAH: https://linkedin.com/in/sarahchenglobal https://instagram.com/sarahchenglobal https://x.com/sarahchenglobal
adbl_web_anon_alc_button_suppression_c
まだレビューはありません